The drugmaker is following in the footsteps of Johnson & Johnson and Eli Lilly in filing suit to force through controversial ...

HRSA warns Sanofi that its credit model for 340B drugs violates the statute, demanding immediate cessation to avoid penalties ...

Sanofi, Johnson & Johnson, Eli Lilly and Bristol Myers Squibb have each filed complaints after facing federal opposition to ...

The Health Resources and Services Administration last week directed Sanofi to cease implementation of its 340B rebate ...

The 340B program has become a flash point in the growing debate over the cost of prescription drugs in the U.S.

Four drug manufacturers have announced plans to offer discounted drug prices to safety net providers under the federal 340B program via ...

Sanofi has filed a lawsuit against the Biden administration over payment terms in a federal drug discount program.

The Health Resources and Services Administration has issued a warning to Sanofi over its plan to implement a new credit model for sales of certain covered outpatient drugs, threatening to remove the ...

AIDS Healthcare Foundation (AHF) welcomes the U.S. Health Resources and Services Administration move against Sanofi’s attack on the 340B Drug Pricing Program. In a letter to Sanofi HRSA Letter to Paul ...

TAKEAWAYS FROM THE HEALTH CARE DEAL — Pharmacy benefit managers may soon have to comply with new regulations under an ...